Summit Therapeutics shares owned by Snowden Capital Advisors
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Snowden Capital Advisors
from 13F filings
Historical chart of Snowden Capital Advisors investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Snowden Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Snowden Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $314k | 15k | 20.66 |
| 2025-06-30 | $317k | 15k | 21.28 |
| 2023-06-30 | $31k | 13k | 2.51 |